Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila
- Address
- lock Available on a paid plan
Stomatognathic Diseases and Oral Surgery
Clinical research at Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila includes studies in stomatognathic diseases focused on preventing bleeding complications after tooth extraction in patients using blood-thinning medicines. The work is aimed at improving oral bleeding control and supporting safer dental care for people at higher risk of postoperative bleeding.
- Preventing clinically relevant bleeding after single or multiple tooth extraction
- Evaluating a new oral approach to reduce postoperative oral bleeding and hematomas
- Supporting safer procedures for patients treated with anticoagulants
This area reflects a practical effort to improve treatment safety and patient outcomes in dentistry and oral medicine.
Bacterial Infections and Urology
The site is also conducting research in bacterial infections related to complicated urinary tract infection and acute pyelonephritis. These studies are designed to compare treatment effectiveness in hospitalized adults and to help identify better options for managing serious urinary infections.
- Complicated urinary tract infection
- Acute pyelonephritis
- Testing an oral antibiotic option against standard intravenous therapy
This research supports advances in urology by exploring whether new treatment strategies can deliver effective infection control while improving convenience for patients and clinicians.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 12 therapeutic areas and 15 of 36 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +10 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila
lock Showing 1 of 39 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome | Janssen Cilag International | Phase III | Not Recruiting | Nov 2023 | Jan 2026 |
IMP list
lock Showing 1 of 36 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 6 | Unknown | 2025-09-25 | 2026-06-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.